Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 20 04:00PM ET
374.52
Dollar change
-1.39
Percentage change
-0.37
%
IndexS&P 500 P/E14.61 EPS (ttm)25.63 Insider Own0.17% Shs Outstand225.64M Perf Week-3.03%
Market Cap84.62B Forward P/E9.56 EPS next Y39.18 Insider Trans-2.17% Shs Float225.55M Perf Month-9.21%
Income5.92B PEG1.38 EPS next Q9.16 Inst Own92.63% Short Float0.98% Perf Quarter-13.76%
Sales183.12B P/S0.46 EPS this Y4.36% Inst Trans-1.81% Short Ratio1.25 Perf Half Y0.33%
Book/sh188.37 P/B1.99 EPS next Y13.62% ROA5.11% Short Interest2.20M Perf Year-29.92%
Cash/sh- P/C- EPS next 5Y10.60% ROE14.24% 52W Range357.45 - 567.26 Perf YTD1.52%
Dividend Est.6.77 (1.81%) P/FCF23.03 EPS past 5Y6.81% ROIC8.38% 52W High-33.98% Beta0.62
Dividend TTM6.68 (1.78%) Quick Ratio- Sales past 5Y11.15% Gross Margin- 52W Low4.78% ATR (14)10.08
Dividend Ex-DateJun 10, 2025 Current Ratio1.43 EPS Y/Y TTM-3.26% Oper. Margin4.82% RSI (14)40.48 Volatility1.00% 1.57%
Employees104200 Debt/Eq0.71 Sales Y/Y TTM6.63% Profit Margin3.23% Recom1.70 Target Price491.39
Option/ShortYes / Yes LT Debt/Eq0.66 EPS Q/Q0.19% Payout25.39% Rel Volume1.67 Prev Close375.91
Sales Surprise5.32% EPS Surprise4.88% Sales Q/Q14.83% EarningsApr 22 BMO Avg Volume1.75M Price374.52
SMA20-1.66% SMA50-6.71% SMA200-11.17% Trades Volume2,934,730 Change-0.37%
Date Action Analyst Rating Change Price Target Change
Apr-15-25Downgrade Robert W. Baird Outperform → Neutral $529
Mar-17-25Upgrade Argus Hold → Buy $450
Jan-22-25Downgrade Stephens Overweight → Equal-Weight $520 → $440
Oct-18-24Downgrade Argus Buy → Hold
Jul-18-24Downgrade BofA Securities Buy → Neutral $646 → $530
Jun-24-24Initiated Morgan Stanley Overweight $643
May-30-24Initiated Robert W. Baird Outperform $649
Mar-06-24Initiated Barclays Overweight $584
Jul-12-23Downgrade Wolfe Research Outperform → Peer Perform
Apr-27-23Upgrade Morgan Stanley Equal-Weight → Overweight $500 → $571
Jun-18-25 06:20AM
Jun-17-25 11:18AM
11:15AM
08:07AM
Jun-15-25 11:36PM
05:39AM Loading…
05:39AM
Jun-12-25 08:01AM
Jun-11-25 11:39AM
12:01AM
Jun-03-25 10:28AM
Jun-02-25 09:03AM
06:11AM
May-28-25 09:11AM
May-23-25 11:13AM
May-22-25 04:55PM
04:45PM Loading…
04:45PM
11:30AM
May-19-25 05:07PM
May-15-25 11:05AM
10:06AM
May-12-25 08:55AM
May-07-25 10:44PM
09:00AM
May-06-25 01:25PM
May-02-25 11:05AM
May-01-25 05:55PM
02:53PM
02:04PM
Apr-30-25 12:57PM
11:30AM
10:30AM Loading…
10:30AM
Apr-29-25 10:59AM
03:08AM
02:01AM
Apr-28-25 11:25PM
10:59AM
08:05AM
Apr-25-25 01:29PM
Apr-24-25 10:28AM
Apr-23-25 04:36PM
10:20AM
03:02AM
Apr-22-25 11:30PM
01:37PM
01:29PM
12:34PM
11:30AM
11:19AM
09:41AM
09:30AM
07:10AM
06:35AM
06:08AM
06:06AM
06:00AM
Apr-21-25 05:35PM
08:30AM
08:03AM
Apr-18-25 04:13PM
Apr-17-25 05:08PM
01:10PM
12:45PM
11:42AM
10:12AM
08:50AM
Apr-16-25 01:15PM
09:15AM
06:20AM
Apr-15-25 10:00AM
08:30AM
12:00AM
Apr-14-25 08:04AM
Apr-13-25 03:06AM
Apr-11-25 10:20PM
03:53PM
Apr-10-25 01:21PM
09:10AM
08:55AM
Apr-09-25 10:17PM
09:38PM
07:10AM
Apr-08-25 07:47AM
06:46AM
Apr-07-25 06:15PM
05:08PM
05:13AM
Apr-06-25 04:46AM
Apr-04-25 12:40PM
Apr-03-25 04:50PM
08:50AM
Apr-02-25 09:52AM
05:04AM
Apr-01-25 11:32AM
10:11AM
08:50AM
Mar-31-25 04:05PM
09:17AM
08:38AM
07:15AM
Mar-30-25 03:25AM
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kaye MarkEVP & CFOApr 24 '25Sale424.824,5881,949,07418,977Apr 25 04:17 PM
Kaye MarkOfficerApr 24 '25Proposed Sale424.814,5881,949,051Apr 24 05:10 PM
Penczek Ronald WCAO & ControllerMar 10 '25Sale415.13443183,9031,847Mar 11 04:20 PM
Penczek Ronald WOfficerMar 10 '25Proposed Sale415.13443183,904Mar 10 02:55 PM
Kendrick Charles Morgan JREVP & President, CommercialMar 05 '25Sale396.303,5041,388,63510,116Mar 05 05:52 PM
Kendrick Charles Morgan JROfficerMar 05 '25Proposed Sale396.303,5041,388,651Mar 05 05:19 PM
Kendrick Charles Morgan JREVP & President, CommercialOct 18 '24Sale432.147,4173,205,1828,423Oct 18 05:21 PM
Kendrick Charles Morgan JRDirectorOct 18 '24Proposed Sale432.287,4173,206,221Oct 18 01:48 PM
PERU RAMIRO GDirectorAug 05 '24Sale531.52753400,2358,744Aug 06 05:23 PM
RAMIRO G PERUDirectorAug 05 '24Proposed Sale531.52753400,235Aug 05 04:14 PM
BOUDREAUX GAILPresident and CEOJul 22 '24Sale500.9834,00017,033,395126,709Jul 23 05:02 PM
Dixon Robert L JRDirectorJul 19 '24Sale506.76305154,5629,721Jul 22 04:30 PM